Reply to Comment on: SUN Classification Criteria for Vogt-Koyanagi-Harada Disease

Affiliations

¹ Center for Clinical Trials and Evidence Synthesis, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
² Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan.
³ Save Sight Institute, Discipline of Ophthalmology, University of Sydney Faculty of Medicine and Health, Sydney, Australia.

Comment

Douglas A Jabs et al. Am J Ophthalmol. 2022 Dec.

. 2022 Dec:244:230-231.

doi: 10.1016/j.ajo.2022.07.027. Epub 2022 Aug 5.

¹ Center for Clinical Trials and Evidence Synthesis, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
² Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan.
³ Save Sight Institute, Discipline of Ophthalmology, University of Sydney Faculty of Medicine and Health, Sydney, Australia.

No abstract available

Comment on

Classification Criteria for Vogt-Koyanagi-Harada Disease.
Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of Uveitis Nomenclature (SUN) Working Group. Am J Ophthalmol. 2021 Aug;228:205-211. doi: 10.1016/j.ajo.2021.03.036. Epub 2021 Apr 9. Am J Ophthalmol. 2021. PMID: 33845018 Free PMC article.
Comment on "SUN Classification Criteria for Vogt-Koyanagi-Harada Disease".
Carreño E, Pichi F, Agarwal A, Munk MR. Carreño E, et al. Am J Ophthalmol. 2022 Dec;244:228-229. doi: 10.1016/j.ajo.2022.07.021. Epub 2022 Aug 5. Am J Ophthalmol. 2022. PMID: 35940245 No abstract available.